CC
ORIC icon

Casdin Capital’s Oric Pharmaceuticals ORIC Stock Holding History

Casdin Capital’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-601,515
Closed -$2.69M – 41
2022
Q2 		$2.69M Hold
601,515
– – 0.23% 36
2022
Q1 		$3.21M Hold
601,515
– – 0.14% 45
2021
Q4 		$8.84M Hold
601,515
– – 0.25% 47
2021
Q3 		$12.6M Hold
601,515
– – 0.31% 43
2021
Q2 		$10.6M Hold
601,515
– – 0.27% 42
2021
Q1 		$14.7M Hold
601,515
– – 0.44% 36
2020
Q4 		$20.4M Buy
601,515
+350,000
+139% +$10M 0.61% 35
2020
Q3 		$6.29M Hold
251,515
– – 0.28% 42
2020
Q2 		$8.48M Buy
+251,515
New +$8.03M 0.5% 37

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return